SGMO Sangamo Therapeutics, Inc.
Healthcare$0.19+7.49%ClosedMarket Cap: $76.7M
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
111
13F Shares
62,263,232
Ownership %
20.5%
New Positions
18
Increased Positions
43
Closed Positions
25
Reduced Positions
34
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Direxion mRNA ETF | 43,436 | 2.26% | |
| Invesco NASDAQ Future Gen 200 ETF | 163,586 | 0.40% | |
| Global X - Genomics & Biotechnology ETF | 244,820 | 0.19% | |
| iShares Neuroscience and Healthcare ETF | 21,725 | 0.14% | |
| Invesco RAFI US 1500 Small-Mid ETF | 881,646 | 0.01% | |
| Schwab U.S. Small-Cap ETF | 1,798,290 | 0.00% | |
| 3,765,296 | 0.00% | ||
| 3,765,296 | 0.00% | ||
| 3,765,296 | 0.00% | ||
| 3,765,296 | 0.00% | ||
| 7,956,969 | 0.00% | ||
| Schwab U.S. Broad Market ETF | 252,248 | 0.00% | |
| 7,956,969 | 0.00% | ||
| 7,956,969 | 0.00% | ||
| Vanguard Total Stock Market ETF | 7,956,969 | 0.00% | |
| 102,568 | 0.00% | ||
| 102,568 | 0.00% | ||
| 186,285 | 0.00% | ||
| 186,285 | 0.00% | ||
| 186,285 | 0.00% |